Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

New and experimental HIV treatments news

Show

From To
Therapeutic HIV vaccines show promise

Attendees at last week's International AIDS Conference heard the results of a handful of successful, but small, early-phase clinical trials for therapeutic HIV vaccines.

Published
28 July 2010
From
Scientific American
Avexa licenses integrase inhibitor to Chinese partner

Avexa has licensed an integrase inhibitor with a similar resistance profile to Merck's Isentress to a Chinese company.

Published
14 July 2010
From
Avexa
LSUHSC awarded $4 million to understand effect of THC on HIV

LSU Health Sciences Center New Orleans has been awarded a $4 million grant over five years to study how THC, a component chemical of marijuana, might reduce inflammation and viral replication in people with HIV, as a basis for future drug discovery.

Published
07 July 2010
From
Moreover.com HIV/AIDS feed
UNMC researchers developing more effective drug delivery for HIV

Instead of multiple pills each day, patients would receive one weekly injection.

Published
01 January 1970
From
Health Canal
← Prev1...5455565758Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.